Loading...
Interpace Biosciences, Inc.
IDXG•PNK
Healthcare
Medical - Diagnostics & Research
$0.77
$0.00(0.00%)
Interpace Biosciences, Inc. (IDXG) Financial Performance & Statements
Review Interpace Biosciences, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
16.69%
↑ 16.69%
Operating Income Growth
189.16%
↑ 189.16%
Net Income Growth
735.66%
↑ 735.66%
Operating Cash Flow Growth
22.62%
↑ 22.62%
Operating Margin
18.82%
↑ 18.82%
Gross Margin
64.82%
↑ 64.82%
Net Profit Margin
16.36%
↑ 16.36%
ROE
-119.25%
↓ 119.25%
ROIC
155.83%
↑ 155.83%
Interpace Biosciences, Inc. (IDXG) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Interpace Biosciences, Inc. stock.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Revenue | $46.93M | $40.21M | $31.84M | $41.31M |
| Cost of Revenue | $17.001M | $16.31M | $13.61M | $23.37M |
| Gross Profit | $29.93M | $23.90M | $18.23M | $17.95M |
| Gross Profit Ratio | $0.64 | $0.59 | $0.57 | $0.43 |
| R&D Expenses | $676000.00 | $636000.00 | $703000.00 | $1.88M |
| SG&A Expenses | $21.14M | $19.60M | $20.10M | $23.74M |
| Operating Expenses | $21.82M | $21.10M | $22.07M | $29.68M |
| Total Costs & Expenses | $38.82M | $37.41M | $35.68M | $53.05M |
| Interest Income | $0.00 | $0.00 | $1.008M | $1.04M |
| Interest Expense | $659000.00 | $1.008M | $1.008M | $920000.00 |
| Depreciation & Amortization | $748000.00 | $1.03M | $2.56M | $5.37M |
| EBITDA | $8.36M | $3.84M | -$2.27M | -$1.33M |
| EBITDA Ratio | $0.18 | $0.10 | -$0.12 | -$0.20 |
| Operating Income | $8.11M | $2.80M | -$3.84M | -$11.74M |
| Operating Income Ratio | $0.17 | $0.07 | -$0.12 | -$0.28 |
| Other Income/Expenses (Net) | -$1.16M | -$1.68M | -$2.22M | -$1.41M |
| Income Before Tax | $6.95M | $1.13M | -$5.84M | -$15.41M |
| Income Before Tax Ratio | $0.15 | $0.03 | -$0.18 | -$0.37 |
| Income Tax Expense | $4000.00 | $17000.00 | $29000.00 | -$667000.00 |
| Net Income | $6.70M | $802000.00 | -$5.87M | -$14.75M |
| Net Income Ratio | $0.14 | $0.02 | -$0.18 | -$0.36 |
| EPS | $1.42 | $0.19 | -$1.38 | -$3.57 |
| Diluted EPS | $0.40 | $0.18 | -$1.38 | -$3.57 |
| Weighted Avg Shares Outstanding | $4.39M | $4.32M | $4.24M | $4.13M |
| Weighted Avg Shares Outstanding (Diluted) | $15.73M | $4.36M | $4.24M | $4.13M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan